Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit (original) (raw)

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer

Elizabeth A Blair, Daniel Haraf

Radiotherapy and Oncology, 2010

View PDFchevron_right

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation

Daniel Haraf

Cancer, 2011

View PDFchevron_right

Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer

Diana Giannarelli

Cancer, 1988

View PDFchevron_right

Induction Chemotherapy Followed By Concurrent Chemoradiotherapy Versus Radiotherapy Alone In Locally Advanced HNSCC – An Experience From Medical College In West Bengal, India

Amitabha Chakrabarty

IRA - international journal of applied sciences, 2016

View PDFchevron_right

Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas

Quynh-thu Le

Cancer, 2006

View PDFchevron_right

Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit

Melonie Nance

Clinical Cancer Research, 2023

View PDFchevron_right

A Prospective Randomised Trial Comparing Neoadjuvant Chemotherapy Followed by Concomitant Chemoradiation versus Concomitant Chemoradiation Alone in Locally Advanced Inoperable Head and Neck Squamous Cell Carcinoma

International Journal of Research & Review (IJRR)

https://www.ijrrjournal.com/IJRR\_Vol.6\_Issue.11\_Nov2019/Abstract\_IJRR0058.html, 2019

View PDFchevron_right

When is chemotherapy in head and neck squamous cell carcinoma not indicated?

Jan Vermorken

European Archives of Oto-Rhino-Laryngology, 2014

View PDFchevron_right

Docetaxel, Cisplatin, Leucovorin and 5- Fluorouracil versus Leucovorin, 5-Fluorouracil, and Cisplatin as Neoadjuvant Chemotherapy Followed by Chemoradiation in Head and Neck Cancer

Akramul Islam

SAS journal of medicine, 2023

View PDFchevron_right

Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study

franco campostrini

Annals of Oncology, 2010

View PDFchevron_right

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer

A. Irigoyen

Annals of Oncology, 2014

View PDFchevron_right

Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fluorouracil, Gemcitabine, and Twice-Daily Radiation in Patients with Poor-Prognosis Cancer of the Head and Neck

Bharat Mittal

Clinical Cancer Research, 2004

View PDFchevron_right

Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial

Latha Kadalayil

Lancet Oncology, 2010

View PDFchevron_right

Head and neck cancer: improving outcomes with a multidisciplinary approach

Marco Merlano

Cancer Management and Research

View PDFchevron_right

Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up

G. Cavaniglia, A. Gava

JNCI Journal of the National Cancer Institute, 2004

View PDFchevron_right

Induction Chemotherapy With Cisplatin and 5-Fluorouracil Followed by Chemoradiotherapy or Radiotherapy Alone In the Treatment of Locoregionally Advanced Resectable …

Ozden Altundag

Head & …, 2005

View PDFchevron_right

Preoperative combination chemotherapy for advanced stage head and neck cancer

Robert Ossoff

The American Journal of Surgery, 1984

View PDFchevron_right

Adjuvant chemotherapy in advanced head and neck cancer☆An update

Rafael santos

American Journal of Surgery, 1982

View PDFchevron_right

Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data

J.-p. Pignon

British Journal of Oral and Maxillofacial Surgery, 2009

View PDFchevron_right

Adjuvant chemotherapy in advanced head and neck cancer

Rafael de los Santos

The American Journal of Surgery, 1982

View PDFchevron_right

Feasibility and Efficacy of Induction Docetaxel, Cisplatin, and 5-Fluorouracil Chemotherapy Combined With Cisplatin Concurrent Chemoradiotherapy for Nonmetastatic Stage IV Head-and-Neck Squamous Cell Carcinomas

Mehmet Sen

International Journal of Radiation Oncology*Biology*Physics, 2011

View PDFchevron_right

Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216)

Ehab Hanna

Head & Neck, 2009

View PDFchevron_right

A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

ekkasit tharavichitkul

Auris Nasus Larynx, 2011

View PDFchevron_right

Efficacy and safety of a cisplatin and paclitaxel (TP) induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC)

Renato Capuzzo

Head & Neck, 2015

View PDFchevron_right

Palliative Chemotherapy in Recurrent or Metastatic Squamous cell carcinoma of the head and neck, NEMROCK experience

Amr Sakr

Research in Oncology

View PDFchevron_right

Cisplatin, Fluorouracil, and Leucovorin Induction Chemotherapy Followed by Concurrent Cisplatin Chemoradiotherapy for Organ Preservation and Cure in Patients With Advanced Head and Neck Cancer: Long-Term Follow-Up

Barbara Burtness

Journal of Clinical Oncology, 2004

View PDFchevron_right

Accelerated Weekly Concomitant Boost Postoperative Radiation Therapy Combined to Concomitant Chemotherapy in Patients With Locally Advanced Head and Neck Cancer

Shelley Bulling

International Journal of Radiation Oncology*Biology*Physics, 2007

View PDFchevron_right

Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034

David Schuller

International Journal of Radiation Oncology*Biology*Physics, 1992

View PDFchevron_right

Accelerated fractionation radiotherapy and late intensification with 2 intra-arterial cisplatin infusions for locally advanced head and neck squamous cell carcinoma

Michael Kam

Head & Neck, 2009

View PDFchevron_right

Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma

Serge Koscielny

Cancer, 2001

View PDFchevron_right

Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fr

Anne Lee

Cancer, 2014

View PDFchevron_right

Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma

Eric Genden

Cancer, 2008

View PDFchevron_right

Sequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience

Dr. Rajesh Kumar Pasricha

Indian Journal of Medical and Paediatric Oncology, 2011

View PDFchevron_right